2m 2m 2m 2m 2m 2m 2m
ANAPTYSBIO (ANAB)
NASDAQ
$71.28+$1.47 (+2.10%)
Price as of Jul 14, 2026 5:05 AM EDT- $2.1BMarket Cap
- 159.04%1-Year Change
- BiotechnologyIndustry
ANAPTYSBIO (ANAB)
$71.28+$1.47 (+2.10%)
ANAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $69.81 | ||
Change | +$3.42 (+5.15%) | ||
Open | $65.22 | ||
High | $70.41 | ||
Low | $64.39 | ||
Previous Close | $66.39 | ||
Volume | 840,574 | ||
30-Day Average Volume | 704,288 | ||
1-Week Change | 12.04% | ||
1-Month Change | 24.51% | ||
1-Year Change | 159.04% | ||
3-Year Change | 275.32% | ||
5-Year Change | 168.50% | ||
Fundamentals | |||
Shares Outstanding | 29.6M | ||
Total Assets | $329.7M | ||
Market Cap | $2.1B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $25.6M | ||
Net Income | -$52.9M | ||
Free Cash Flow | -$25.9M | ||
EBIT | -$52.8M | ||
EBITDA | -$52.7M | ||
Net Working Capital | $274.4M | ||
EPS | -$1.84 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | 71 | ||
P/B | 162 | ||
P/E | -38 | ||
PEG | 0 | ||
Price/Free Cash Flow | -80 | ||
Price/Operating Cash Flow | -80 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue